Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash flows from operating activities:
Net income including noncontrolling interests	$ 150,157	$ 160,536
Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization	24,056	20,354
Share-based compensation expense related to equity classified awards	19,899	15,319
Non-cash restructuring charges	1,171	0
Amortization and write-off of program rights	205,275	218,626
Amortization of deferred carriage fees	2,710	4,401
Unrealized foreign currency transaction gain	(4,501)	(4,582)
Unrealized gain on derivative contracts, net	0	(13,984)
Amortization of deferred financing costs and discounts on indebtedness	1,954	1,881
Bad debt expense	2,353	914
Deferred income taxes	(8,858)	31,800
Write-down of non-marketable equity securities and note receivable	17,741	0
Other, net	1,142	(2,348)
Changes in assets and liabilities:
Accounts receivable, trade (including amounts due from related parties, net)	(1,429)	(17,877)
Prepaid expenses and other assets	(26,233)	(5,512)
Program rights and obligations, net	(190,651)	(248,642)
Income taxes payable	40,114	15,723
Deferred revenue	(4,200)	4,980
Deferred carriage fees, net	(422)	(1,610)
Accounts payable, accrued liabilities and other liabilities	(58,591)	(63,007)
Net cash provided by operating activities	171,687	116,972
Cash flows from investing activities:
Capital expenditures	(22,053)	(11,942)
Return of capital from investees	3,908	172
Investment in and loans to investees	0	(42,318)
Net cash used in investing activities	(18,145)	(54,088)
Cash flows from financing activities:
Proceeds from the issuance of long-term debt	2,521	0
Principal payments on long-term debt	(3,238)	0
Deemed repurchases of restricted stock units	(22,959)	(15,354)
Purchase of treasury stock	(991)	(83,637)
Proceeds from stock option exercises	4,630	0
Principal payments on finance lease obligations	(1,309)	(1,406)
Distributions to noncontrolling interests	(5,629)	(1,435)
Net cash used in financing activities	(26,975)	(101,832)
Net increase (decrease) in cash and cash equivalents from operations	126,567	(38,948)
Effect of exchange rate changes on cash and cash equivalents	2,229	9,365
Cash and cash equivalents at beginning of period	554,886	558,783
Cash and cash equivalents at end of period	$ 683,682	$ 529,200